Intangible Assets, Net (Excluding Goodwill) of BIO-TECHNE Corp from 30 Jun 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Summary
BIO-TECHNE Corp quarterly Intangible Assets, Net (Excluding Goodwill) in USD history and change rate from 30 Jun 2015 to 30 Sep 2025.
  • BIO-TECHNE Corp Intangible Assets, Net (Excluding Goodwill) for the quarter ending 30 Sep 2025 was $350,107,000, a 28% decline year-over-year.
Source SEC data
View on sec.gov
Intangible Assets, Net (Excluding Goodwill), Quarterly (USD)
Intangible Assets, Net (Excluding Goodwill), YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Intangible Assets, Net (Excluding Goodwill) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $350,107,000 -$135,897,000 -28% 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $365,599,000 -$141,482,000 -28% 30 Jun 2025 10-Q 05 Nov 2025 2026 Q1
Q1 2025 $443,699,000 -$82,729,000 -16% 31 Mar 2025 10-Q 08 May 2025 2025 Q3
Q4 2024 $461,051,000 -$89,554,000 -16% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q2
Q3 2024 $486,004,000 -$92,967,000 -16% 30 Sep 2024 10-Q 05 Nov 2024 2025 Q1
Q2 2024 $507,081,000 -$27,564,000 -5.2% 30 Jun 2024 10-K 22 Aug 2025 2025 FY
Q1 2024 $526,428,000 -$26,829,000 -4.8% 31 Mar 2024 10-Q 06 May 2024 2024 Q3
Q4 2023 $550,605,000 -$17,042,000 -3% 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $578,971,000 -$6,563,000 -1.1% 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q2 2023 $534,645,000 +$3,123,000 +0.59% 30 Jun 2023 10-K 22 Aug 2025 2025 FY
Q1 2023 $553,257,000 +$1,915,000 +0.35% 31 Mar 2023 10-Q 08 May 2023 2023 Q3
Q4 2022 $567,647,000 -$1,700,000 -0.3% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q2
Q3 2022 $585,534,000 -$30,434,000 -4.9% 30 Sep 2022 10-Q 07 Nov 2022 2023 Q1
Q2 2022 $531,522,000 -$84,446,000 -14% 30 Jun 2022 10-K 22 Aug 2024 2024 FY
Q1 2022 $551,342,000 +$62,164,000 +13% 31 Mar 2022 10-Q 09 May 2022 2022 Q3
Q4 2021 $569,347,000 +$65,175,000 +13% 31 Dec 2021 10-Q 07 Feb 2022 2022 Q2
Q3 2021 $615,968,000 +$108,377,000 +21% 30 Sep 2021 10-Q 07 Feb 2022 2022 Q2
Q2 2021 $615,968,000 +$99,423,000 +19% 30 Jun 2021 10-K 23 Aug 2023 2023 FY
Q1 2021 $489,178,000 -$41,155,000 -7.8% 31 Mar 2021 10-Q 07 May 2021 2021 Q3
Q4 2020 $504,172,000 -$45,540,000 -8.3% 31 Dec 2020 10-Q 08 Feb 2021 2021 Q2
Q3 2020 $507,591,000 -$55,747,000 -9.9% 30 Sep 2020 10-Q 09 Nov 2020 2021 Q1
Q2 2020 $516,545,000 -$62,884,000 -11% 30 Jun 2020 10-K 24 Aug 2022 2022 FY
Q1 2020 $530,333,000 -$48,809,000 -8.4% 31 Mar 2020 10-Q 11 May 2020 2020 Q3
Q4 2019 $549,712,000 -$58,561,000 -9.6% 31 Dec 2019 10-Q 06 Feb 2020 2020 Q2
Q3 2019 $563,338,000 -$69,348,000 -11% 30 Sep 2019 10-Q 06 Nov 2019 2020 Q1
Q2 2019 $579,429,000 +$133,097,000 +30% 30 Jun 2019 10-K 25 Aug 2021 2021 FY
Q1 2019 $579,142,000 +$135,348,000 +30% 31 Mar 2019 10-Q 07 May 2019 2019 Q3
Q4 2018 $608,273,000 +$169,913,000 +39% 31 Dec 2018 10-Q 07 Feb 2019 2019 Q2
Q3 2018 $632,686,000 +$181,662,000 +40% 30 Sep 2018 10-Q 07 Nov 2018 2019 Q1
Q2 2018 $446,332,000 -$5,710,000 -1.3% 30 Jun 2018 10-K 26 Aug 2020 2020 FY
Q1 2018 $443,794,000 -$38,899,000 -8.1% 31 Mar 2018 10-Q 09 May 2018 2018 Q3
Q4 2017 $438,360,000 -$55,182,000 -11% 31 Dec 2017 10-Q 08 Feb 2018 2018 Q2
Q3 2017 $451,024,000 -$52,602,000 -10% 30 Sep 2017 10-Q 09 Nov 2017 2018 Q1
Q2 2017 $452,042,000 +$141,518,000 +46% 30 Jun 2017 10-K/A 06 Nov 2019 2019 FY
Q1 2017 $482,693,000 31 Mar 2017 10-Q 10 May 2017 2017 Q3
Q4 2016 $493,542,000 31 Dec 2016 10-Q 09 Feb 2017 2017 Q2
Q3 2016 $503,626,000 30 Sep 2016 10-Q 09 Nov 2016 2017 Q1
Q2 2016 $310,524,000 +$17,685,000 +6% 30 Jun 2016 10-K 27 Aug 2018 2018 FY
Q2 2015 $292,839,000 30 Jun 2015 10-K 07 Sep 2017 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.